According to Xencor's latest financial reports and stock price the company's current number of shares outstanding is 60,621,534. At the end of 2023 the company had 60,621,534 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 60.62 M | 1.18% |
2022 | 59.91 M | 2.8% |
2021 | 58.27 M | 1.22% |
2020 | 57.57 M | 1.41% |
2019 | 56.77 M | 0.94% |
2018 | 56.24 M | 19.75% |
2017 | 46.96 M | 10.22% |
2016 | 42.61 M | 5.22% |
2015 | 40.5 M | 28.85% |
2014 | 31.43 M | 0.25% |
2013 | 31.35 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 3,870.87% | ๐บ๐ธ USA |
AbbVie ABBV | 1,765,940,733 | 2,813.06% | ๐บ๐ธ USA |
Amgen AMGN | 535,000,000 | 782.52% | ๐บ๐ธ USA |
Merck MRK | 2,554,166,667 | 4,113.30% | ๐บ๐ธ USA |
Seagen
SGEN | 188,135,000 | 210.34% | ๐บ๐ธ USA |
MacroGenics MGNX | 61,980,680 | 2.24% | ๐บ๐ธ USA |